Michielan A, D'Inc R
Cardiovascular-Kidney-Metabolic (CKM) Syndrome , as defined by the AHA, is a systemic disorder characterized by pathophysiological interactions among metabolic risk factors (such as obesity, insulin resistance, dyslipidemia, and hypertension), chronic kidney disease (CKD), and the cardiovascular system, leading to multiorgan dysfunction and a high rate of adverse cardiovascular outcomes [145]
This continuous stimulation may support cellular hypertrophy and improved recovery parameters in research settings
And then anything else for stage two or should we go on to three
These pleiotropic actions are mediated through a complex network of interconnected molecular pathways, underscoring SFNs value as a multi-targeted agent in oncology and providing a mechanistic basis for its synergy with conventional therapies
Oxidative stress further impairs granulosa cell function by reducing antioxidant capacity, steroidogenesis, and follicle-stimulating hormone receptor expression, contributing to abnormal follicular development (33)
